SFO ENDS GSK AND ROLLS-ROYCE GRAFT PROBES
February 1st, 2019
BRITAIN’S Serious Fraud Office (SFO) has closed two long-running major investigations into allegations of corruption and bribery at two of the UK’s largest companies: aero-engine maker Rolls-Royce and medicine manufacturer GlaxoSmithKline. Rolls-Royce has been subject to a deferred prosecution agreement (DPA), approved in January 2017, where it paid a GBP497.25 million (USD616 million) plus interest penalty and GBP13 million costs (USD16.1 million) over 12 counts of conspiracy to corrupt, false accounting and failure to prevent bribery in Indonesia, Thailand, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.